|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008059,
umls-concept:C0012634,
umls-concept:C0030685,
umls-concept:C0036043,
umls-concept:C0079466,
umls-concept:C0205653,
umls-concept:C0231449,
umls-concept:C0391871,
umls-concept:C0424295,
umls-concept:C0443252,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1963578
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-6-12
|
|
pubmed:abstractText |
Short-term, controlled studies of extended-release guanfacine (GXR), a selective alpha(2A)-adrenoreceptor agonist, demonstrate efficacy in treating attention-deficit/hyperactivity disorder (ADHD) symptoms as monotherapy. This 2-year open-label study was conducted to further assess the long-term safety and efficacy of GXR.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1557-8992
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
215-26
|
|
pubmed:meshHeading |
pubmed-meshheading:19519256-Adolescent,
pubmed-meshheading:19519256-Adrenergic alpha-Agonists,
pubmed-meshheading:19519256-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:19519256-Central Nervous System Stimulants,
pubmed-meshheading:19519256-Child,
pubmed-meshheading:19519256-Delayed-Action Preparations,
pubmed-meshheading:19519256-Dose-Response Relationship, Drug,
pubmed-meshheading:19519256-Drug Therapy, Combination,
pubmed-meshheading:19519256-Female,
pubmed-meshheading:19519256-Follow-Up Studies,
pubmed-meshheading:19519256-Guanfacine,
pubmed-meshheading:19519256-Humans,
pubmed-meshheading:19519256-Male,
pubmed-meshheading:19519256-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
|
|
pubmed:affiliation |
Department of Psychiatry, University of Cincinnati, Cincinnati, Ohio 45219, USA. floyd.sallee@uc.edu
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
